BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 25948224)

  • 21. Synergistic activity of bortezomib and HDACi in preclinical models of B-cell precursor acute lymphoblastic leukemia via modulation of p53, PI3K/AKT, and NF-κB.
    Bastian L; Hof J; Pfau M; Fichtner I; Eckert C; Henze G; Prada J; von Stackelberg A; Seeger K; Shalapour S
    Clin Cancer Res; 2013 Mar; 19(6):1445-57. PubMed ID: 23357978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
    Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
    Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
    Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
    J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M; Feo F; Pascale RM
    J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia.
    Agirre X; Román-Gómez J; Jiménez-Velasco A; Garate L; Montiel-Duarte C; Navarro G; Vázquez I; Zalacain M; Calasanz MJ; Heiniger A; Torres A; Minna JD; Prósper F
    Oncogene; 2006 Mar; 25(13):1862-70. PubMed ID: 16314841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
    Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
    Halldórsdóttir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Göransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
    Am J Hematol; 2012 Apr; 87(4):361-7. PubMed ID: 22374828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of epigenetic regulatory mechanisms in neonatal hypoxic-ischemic brain injury.
    Kumral A; Tuzun F; Tugyan K; Ozbal S; Yılmaz O; Yesilirmak CD; Duman N; Ozkan H
    Early Hum Dev; 2013 Mar; 89(3):165-73. PubMed ID: 23046993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB (RelB/p52) in non-Hodgkin's lymphoma cells.
    Lwin T; Hazlehurst LA; Li Z; Dessureault S; Sotomayor E; Moscinski LC; Dalton WS; Tao J
    Leukemia; 2007 Jul; 21(7):1521-31. PubMed ID: 17476277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The biological and clinical impact of inhibition of NF-κB-initiated apoptosis in diffuse large B cell lymphoma (DLBCL).
    Bavi P; Uddin S; Bu R; Ahmed M; Abubaker J; Balde V; Qadri Z; Ajarim D; Al-Dayel F; Hussain AR; Al-Kuraya KS
    J Pathol; 2011 Jul; 224(3):355-66. PubMed ID: 21506127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance to Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis and constitutive expression of Apo2L/TRAIL in human T-cell leukemia virus type 1-infected T-cell lines.
    Matsuda T; Almasan A; Tomita M; Uchihara JN; Masuda M; Ohshiro K; Takasu N; Yagita H; Ohta T; Mori N
    J Virol; 2005 Feb; 79(3):1367-78. PubMed ID: 15650163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic alteration of the NF-κB-inducing kinase (NIK) gene is involved in enhanced NIK expression in basal-like breast cancer.
    Yamamoto M; Ito T; Shimizu T; Ishida T; Semba K; Watanabe S; Yamaguchi N; Inoue J
    Cancer Sci; 2010 Nov; 101(11):2391-7. PubMed ID: 20735436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic changes in the DAP-kinase CpG island in pediatric lymphoma.
    Shiramizu B; Mick P
    Med Pediatr Oncol; 2003 Dec; 41(6):527-31. PubMed ID: 14595709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Huerta-Yepez S; Vega M; Garban H; Bonavida B
    Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional regulation of the human GD3 synthase gene expression in Fas-induced Jurkat T cells: a critical role of transcription factor NF-kappaB in regulated expression.
    Kang NY; Kang SK; Lee YC; Choi HJ; Lee YS; Cho SY; Kim YS; Ko JH; Kim CH
    Glycobiology; 2006 May; 16(5):375-89. PubMed ID: 16481330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ebselen sensitizes glioblastoma cells to Tumor Necrosis Factor (TNFalpha)-induced apoptosis through two distinct pathways involving NF-kappaB downregulation and Fas-mediated formation of death inducing signaling complex.
    Sharma V; Tewari R; Sk UH; Joseph C; Sen E
    Int J Cancer; 2008 Nov; 123(9):2204-12. PubMed ID: 18709644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis.
    Hezaveh K; Kloetgen A; Bernhart SH; Mahapatra KD; Lenze D; Richter J; Haake A; Bergmann AK; Brors B; Burkhardt B; Claviez A; Drexler HG; Eils R; Haas S; Hoffmann S; Karsch D; Klapper W; Kleinheinz K; Korbel J; Kretzmer H; Kreuz M; Küppers R; Lawerenz C; Leich E; Loeffler M; Mantovani-Loeffler L; López C; McHardy AC; Möller P; Rohde M; Rosenstiel P; Rosenwald A; Schilhabel M; Schlesner M; Scholz I; Stadler PF; Stilgenbauer S; Sungalee S; Szczepanowski M; Trümper L; Weniger MA; Siebert R; Borkhardt A; Hummel M; Hoell JI;
    Haematologica; 2016 Nov; 101(11):1380-1389. PubMed ID: 27390358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Association between Abnormal Long Noncoding RNA MALAT-1 Expression and Cancer Lymph Node Metastasis: A Meta-Analysis.
    Wang J; Pan Y; Wu J; Zhang C; Huang Y; Zhao R; Cheng G; Liu J; Qin C; Shao P; Hua L; Wang Z
    Biomed Res Int; 2016; 2016():1823482. PubMed ID: 26989678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNAs in diffuse large B-cell lymphoma.
    Ni H; Tong R; Zou L; Song G; Cho WC
    Oncol Lett; 2016 Feb; 11(2):1271-1280. PubMed ID: 26893730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Omega-3 fatty acid protects cardiomyocytes against hypoxia-induced injury through targeting MiR-210-3p/CASP8AP2 axis.
    Yu X; Liu F; Liu Y; Bai B; Yin H; Wang H; Feng Y; Ma H; Geng Q
    Mol Cell Biochem; 2021 Aug; 476(8):2999-3007. PubMed ID: 33791918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.